A Safety and Effectiveness Study of SABER®-Bupivacaine for Pain Following Shoulder Surgery
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This is a research study testing SABER-Bupivacaine (an experimental pain-relieving
medication). SABER-Bupivacaine is designed to continuously deliver bupivacaine, a common
local anesthetic, for a few days in order to treat local post-surgical pain.
The purpose of this study is to investigate safety (if there are any side effects) associated
with the use of SABER-Bupivacaine and how well it works in reducing pain and opioid-related
side effects following shoulder surgery.